✦ LIBER ✦

Effects of the combined blockade of EGFR and ErbB-2 on signal transduction and regulation of cell cycle regulatory proteins in breast cancer cells

✍ Scribed by Amelia D’Alessio; Antonella De Luca; Monica R. Maiello; Luana Lamura; Anna Maria Rachiglio; Maria Napolitano; Marianna Gallo; Nicola Normanno

Publisher: Springer US
Year: 2009
Tongue: English
Weight: 584 KB
Volume: 123
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-009-0649-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hormonal regulation of the Grb14 signal

Hormonal regulation of the Grb14 signal modulator and its role in cell cycle progression of MCF-7 human breast cancer cells

✍ Rania Kairouz; Jayamala Parmar; Ruth J. Lyons; Alexander Swarbrick; Elizabeth A. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB 👁 1 views

## Abstract Growth factor receptor bound (Grb)14 is a member of the Grb7 family of src homology (SH)2 domain‐containing proteins. These proteins perform both adaptor and modulatory roles in receptor tyrosine kinase (RTK) signaling, although their regulation is poorly understood. In this study, a po

Identifying the differential effects of

Identifying the differential effects of silymarin constituents on cell growth and cell cycle regulatory molecules in human prostate cancer cells

✍ Gagan Deep; Nicholas H. Oberlies; David J. Kroll; Rajesh Agarwal 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 560 KB

## Abstract Prostate cancer (PCa) is the leading cause of cancer‐related deaths in men; urgent measures are warranted to lower this deadly malignancy. Silymarin is a known cancer chemopreventive agent, but the relative anticancer efficacy of its constituents is still unknown. Here, we compared the

Notch-1 regulates Akt signaling pathway

Notch-1 regulates Akt signaling pathway and the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines

✍ Dongmei Guo; Jingjing Ye; Jianjian Dai; Lizhen Li; Feng Chen; Daoxin Ma; Chunyan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 937 KB

Gain-of-function mutations in Notch-1 are common in T-cell lymphoblastic leukemia (T-ALL), making this receptor a promising target for drugs such as gamma-secretase inhibitors (GSIs). However, GSIs seem to be active in only a small fraction of T-ALL cell lines with constitutive Notch-1 activity and

In VitroEffects on MCF-7 Breast Cancer C

In VitroEffects on MCF-7 Breast Cancer Cells Of Signal Transduction Inhibitor/Tamoxifen/Eicosapentaenoic Acid Combinations and their Simultaneous Delivery Across Skin

✍ Zoë Davison; Carol Dutkowski; Julia M. W. Gee; Robert I. Nicholson; Charles M. H 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 346 KB

Estrogen receptor beta increases the eff

Estrogen receptor beta increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells

✍ Leslie Hodges-Gallagher; Cathleen D. Valentine; Suzy El Bader; Peter J. Kushner 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 373 KB

Effects of tyrosine kinase inhibitors on

Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the RAS signaling pathway

✍ Jeffrey W. Clark; Anabela Santos-Moore; Lisa E. Stevenson; A. Raymond Frackelton 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 698 KB

Breast cancers frequently over-express a number of growth factor receptors. In addition, elevated src family kinase activity is present in a percentage of these neoplasms and has been implicated in signal transduction in these cells. Therefore, inhibiting tyrosine kinase activity is a potential appr